While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily toward branded drugmakers, generic medicines and the companies that ...

With Big Pharma pressing the limits in promoting and pricing prescription medications, patients and their advocates long have hoped that generic drugs might be difference-makers on costs and practices ...

When Akorn Pharmaceuticals shut its doors in February, hospitals across the country felt it. The Lake Forest, Illinois-based drugmaker was responsible for producing 75 generic drugs, all of which were ...

Dozens of companies have pledged to build more manufacturing in the U.S. since President Trump took office. Generic drugmakers aren’t among them. And they have no plans to change that anytime soon.

On Friday, the Food and Drug Administration announced a new pilot prioritization program for the review of abbreviated new drug applications that aims to spur and reward investment in U.S. drug ...

Oxford operates one of America's few remaining facilities engaged in domestic generic pharmaceutical manufacturing, transforming raw ingredients into finished medicines. "I want to thank Chairman ...